Why Moderna’s Cancer Vaccine Matters to Investors

Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient’s unique biology. Recent clinical results from Moderna, Inc. (MRNA) bring this shift […]
The post Why Moderna’s Cancer Vaccine Matters to Investors appeared first on ETF Trends.